CDC is investigating the death of a Virginia woman who died after receiving the Johnson & Johnson vaccine
BREAKING: CDC Investigates Death of Virginia Woman Who Died After Receiving Johnson & Johnson Vaccine Last Month
- A woman in Virginia died in March after receiving the Johnson & Johnson vaccine
- The news was announced Tuesday, when the CDC called for a stop on their jab
- The CDC said six people had developed blood clots after J & J’s vaccine
- In the United States, more than 6.8 million people have received J & J’s vaccine
- The CDC will meet on April 14 to review the evidence and reassess J&J
Virginia stops using Johnson & Johnson’s COVID vaccine after a woman died following her vaccination in March.
The Centers for Disease Control and Prevention (CDC) is investigating the woman’s death, Virginian health authorities announced Tuesday.
The news of her death and Virginia’s decision to stop using the J&J vaccine came the day the CDC recommended interrupting the company’s use of the jabs.
Their recommendation was made after six patients, of the 6.8 million who had received the injection to date, reported blood clots.
A woman in Virginia died after receiving the Johnson & Johnson COVID vaccine in March
The patients were all women, aged 18-48, who had cerebral venous sinus thrombosis (CVST) six to thirteen days after receiving the injection.
It’s too early to say if the vaccine even caused the blood clots and it’s a one in a million side effect.
In the US, five times as many people have died from COVID-19 than from blood clots ever.
However, the agencies say they want to do more tests and studies and it could take days for them to decide whether or not to resume it.
They can restrict the vaccine based on the demographics of people who have developed blood clots – they’re all women under 50.
The White House tried on Tuesday to iron out the sudden abandonment of the Johnson and Johnson COVID-19 vaccine, claiming it would not affect their goals to vaccinate the US – despite health experts saying it would clear the country’s rollout. slows down.
President Joe Biden said in the Oval Office Tuesday, “I made sure we have 600 million doses of the mRNA – not from Johnson & Johnson or AstraZeneca.
“So there is enough vaccine that is essentially 100 percent indisputable for any lonely American,” he said.
Pfizer said it increased production by 10 percent in light of the J&J shutdown.
Now it says it will deliver 220 million doses by the end of May.
The US has only fully vaccinated 28 percent of the population.
It is behind Israel, Bahrain and Chile, all of which have significantly smaller economies and populations.
When we count how many first doses of vaccine have been issued, the UK ranks third in the world after Israel and Chile, and the US in fifth instead of fourth.
About a million people per week (142,857 per day) receive the J&J vaccine.
It is significantly less than the number who receive Pfizer and Moderna doses (5 million per week, 714,285 per day).